L-dopa-induced peak-dose dyskinesias in patients with Parkinson's disease: A clinical pharmacologic approach

被引：0
|
作者：
Rascol, O
机构：
[1] INSERM U455, Clin Pharmacol Lab, F-31073 Toulouse, France
[2] Univ Hosp, Clin Invest Ctr, F-31073 Toulouse, France
来源：
MOVEMENT DISORDERS | 1999年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：19 / 32
页数：14
相关论文
共 50 条
  • [1] Serotonergic mediated peak-dose L-DOPA-induced dyskinesias in Parkinson's disease
    Politis, M.
    Wu, K.
    Loane, C.
    Kiferle, L.
    Molloy, S.
    Bain, P.
    Brooks, D.
    Piccini, P.
    MOVEMENT DISORDERS, 2012, 27 : S250 - S250
  • [2] The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease
    Vidailhet, M
    Bonnet, AM
    Marconi, R
    Durif, F
    Agid, Y
    MOVEMENT DISORDERS, 1999, 14 : 13 - 18
  • [3] Tetrabenazine improves levodopa-induced peak-dose dyskinesias in patients with Parkinson's disease
    Brusa, Livia
    Orlacchio, Antonio
    Stefani, Alessandro
    Galati, Salvatore
    Pierantozzi, Mariangela
    Iani, Cesare
    Mercuri, Nicola Biagio
    FUNCTIONAL NEUROLOGY, 2013, 28 (02) : 101 - 105
  • [4] Movement patterns of peak-dose levodopa-induced dyskinesias in patients with Parkinson's disease
    Gour, Jackie
    Edwards, Roderick
    Lemieux, Sarah
    Ghassemi, Mehrdad
    Jog, Mandar
    Duval, Christian
    BRAIN RESEARCH BULLETIN, 2007, 74 (1-3) : 66 - 74
  • [5] Cortical motor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesia
    Rascol, O
    Sabatini, U
    Brefel, C
    Fabre, N
    Rai, S
    Senard, M
    Celsis, P
    Viallard, G
    Montastruc, JL
    Chollet, F
    BRAIN, 1998, 121 : 527 - 533
  • [6] Beneficial effects of amantadine on L-Dopa-induced dyskinesias in Parkinson's disease
    Luginger, E
    Wenning, GK
    Bösch, S
    Poewe, W
    MOVEMENT DISORDERS, 2000, 15 (05) : 873 - 878
  • [7] Serotonergic antidepressant drugs and L-dopa-induced dyskinesias in Parkinson's disease
    Mazzucchi, S.
    Frosini, D.
    Ripoli, A.
    Nicoletti, V.
    Linsalata, G.
    Bonuccelli, U.
    Ceravolo, R.
    ACTA NEUROLOGICA SCANDINAVICA, 2015, 131 (03): : 191 - 195
  • [8] Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study
    Svenningsson, Per
    Rosenblad, Carl
    Arvidsson, Karolina af Edholm
    Wictorin, Klas
    Keywood, Charlotte
    Shankar, Bavani
    Lowe, David A.
    Bjorklund, Anders
    Widner, Hakan
    BRAIN, 2015, 138 : 963 - 973
  • [9] Social and economic cost of L-Dopa-induced dyskinesias in patients with Parkinson's disease.
    Maurel, F
    Lilliu, H
    Le Pen, C
    REVUE NEUROLOGIQUE, 2001, 157 (05) : 507 - 514
  • [10] Differential Genetic Susceptibility in Diphasic and Peak-Dose Dyskinesias in Parkinson's Disease
    Lee, Jee-Young
    Cho, Jinwhan
    Lee, Eun-Kyung
    Park, Sung-Sup
    Jeon, Beom S.
    MOVEMENT DISORDERS, 2011, 26 (01) : 73 - 79
12345